Tilray(US:TLRY) Globenewswire·2025-09-30 11:00Core Insights - Tilray Medical is expanding its Tilray Craft portfolio in Germany with five new cannabis flower products produced at its EU-GMP certified facility in Neumünster, reflecting its commitment to providing diverse, quality medical cannabis options for patients [1][2][3] Company Overview - Tilray Medical is dedicated to transforming lives by providing safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Craft, and has established itself as a leading supplier of medical cannabis [5] - The company has evolved from being one of the first licensed producers of medical cannabis in Canada to building GMP-certified production facilities in Portugal and Germany [5] Product Details - The new Tilray Craft products are available by prescription at pharmacies throughout Germany, showcasing the company's dedication to advancing medical cannabis innovation and supporting healthcare professionals [3] - Tilray Craft focuses on high potency flower, cultivated indoors in Neumünster, with an emphasis on precision and quality control to ensure reliable medical cannabis for patients [4] Commitment to Quality - The production process at Tilray's facility adheres to rigorous quality control standards, ensuring that the medical cannabis provided is consistent and dependable for patient needs [2][4] - The company prioritizes patient care and aims to deliver consistent, quality solutions to physicians and pharmacies, placing patients' needs first [2]